Amsterdam, Netherlands – February 18, 2026 – The SCRS European Site Solutions Summit is one of the premier gatherings for clinical research professionals in Europe, bringing together site leaders, sponsors, and solution providers to exchange insights and build meaningful collaborations. Revival Research Institute, LLC will be attending the Summit on March 2–3, 2026 in Amsterdam, continuing its commitment to connecting with partners and advancing clinical research across the region.
Meet the Revival Team
Representing Revival Research Institute at the Summit are:
Nicole Stiff
Meirvat Elsir
Kseniya Tymko
Business Development Director, Pharmbiotest Poland
The Summit provides the perfect setting to discuss site capabilities, feasibility opportunities, and potential collaborations. Attendees are invited to meet our team to learn how Revival supports both early- and late-phase studies while maintaining high-quality, patient-centered research.
Highlighting Expansion into Poland
This year, Revival is also showcasing its expansion into Poland, where it is establishing a dedicated Phase I clinical research facility. This new site strengthens Revival’s European presence, enhances early-phase capabilities, and ensures sponsors have access to reliable, compliant, and efficient research operations.
Why We Attend
The Summit isn’t just about presentations or networking, it’s about learning what’s really happening in clinical research across Europe. Revival is attending to share experiences, exchange ideas, and explore partnerships that improve trial execution and patient outcomes.
By connecting with peers, sponsors, and industry leaders, Revival aims to build collaborations that drive innovation and strengthen clinical research infrastructure across the region.
About Revival Research Institute, LLC
Revival Research Institute, LLC is a clinical research organization dedicated to advancing healthcare through high-quality, patient-focused clinical trials. With accredited sites across the U.S. and expanding operations in Europe, Revival has conducted hundreds of Phase I–IV studies across therapeutic areas. The organization partners with sponsors to deliver reliable, compliant research while ensuring every participant is treated with care, respect, and clear communication.
For inquiries or more information
248-721-9539
info@rev-research.com
23999 Northwestern Hwy Southfield, MI 48075
